Physician profile

Keith D Thorne

Cardiovascular Disease · Jackson, MS

NPI 1467559476

$1,103.31

in general payments reported to CMS, 2019-2025

16 companies · $62.78 in 2025

The $62.78 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$264.08

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $430.59 2019-2023
Boston Scientific Corporation $124.58 2023-2025 Latitude Communicator Power Supply, Watchman Access System, Watchman
Irhythm Technologies, INC. $99.99 2019-2022
Boehringer Ingelheim Pharmaceuticals, INC. $96.01 2021-2022
Pfizer INC. $58.80 2019-2025
E.R. Squibb & Sons, L.L.C. $56.22 2022-2023 Eliquis
Bardy Diagnostics, INC. $45.00 2022
Heartflow, INC. $34.88 2022
Amgen INC. $27.48 2025 Repatha
Bayer Healthcare Pharmaceuticals INC. $24.83 2022
Ge Healthcare $22.00 2022
Abiomed $20.69 2021
Merck Sharp & Dohme LLC $17.05 2022
Medtronic, INC. $15.87 2023 Cobalt Dr Mri Surescan
Impulse Dynamics (USA) INC. $15.25 2023 Optimizer
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Kiniksa Pharmaceuticals, LTD. $14.07 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Keith D Thorne

$1,103.31

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $62.78 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/112251/keith-d-thorne

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.